Asahi Kasei to buy Swedish drugmaker Calliditas for $1.1 billion
TOKYO (Reuters) – Japan’s Asahi Kasei said on Tuesday it offered to acquire Calliditas Therapeutics for about 11.8 billion Swedish crowns ($1.1 billion) as part of a plan to become a global drug company. The Japanese firm will offer 208 crowns per share of Stockholm-based Calliditas and 416 crowns for each American depositary share in …
Asahi Kasei to buy Swedish drugmaker Calliditas for $1.1 billion Read More »








